Cargando…
Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
INTRODUCTION: Atrial fibrillation (AF) is the most common cause of ischemic stroke (IS). Atrial fibrillation patients are recommended to use oral anticoagulants (OACs) as part of prevention against IS. However, despite having a therapeutic intensity of OAC therapy, IS can still occur in such patient...
Autores principales: | Wańkowicz, Paweł, Nowacki, Przemysław, Gołąb-Janowska, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764304/ https://www.ncbi.nlm.nih.gov/pubmed/31572466 http://dx.doi.org/10.5114/aoms.2018.77546 |
Ejemplares similares
-
Atrial fibrillation risk factors in patients with ischemic stroke
por: Wańkowicz, Paweł, et al.
Publicado: (2019) -
Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis
por: Kotlęga, Dariusz, et al.
Publicado: (2019) -
Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke
por: Gołąb-Janowska, Monika, et al.
Publicado: (2018) -
Erratum to “Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke”
por: Gołąb-Janowska, Monika, et al.
Publicado: (2020) -
The Association of Free Fatty Acids and Eicosanoids with the Severity of Depressive Symptoms in Stroke Patients
por: Kotlega, Dariusz, et al.
Publicado: (2020)